Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 70,837 | 69,558 | 209,908 | 33,917 | 0 |
| Cost of Goods | 5,949 | 2,529 | 3,301 | 1,393 | N/A |
| Gross Profit | 64,888 | 67,029 | 206,607 | 32,524 | N/A |
| Operating Expenses | 196,491 | 233,544 | 330,252 | 294,637 | 219,263 |
| Operating Income | -130,654 | -165,986 | -123,344 | -261,720 | -219,263 |
| Interest Expense | 50,211 | 46,325 | 36,731 | 18,340 | 4,926 |
| Other Income | 23,185 | 11,364 | 3,174 | 28,555 | -21,774 |
| Pre-tax Income | -157,680 | -200,947 | -156,901 | -251,505 | -245,963 |
| Income Tax | 166 | 39,106 | 227 | -21,479 | 327 |
| Net Income Continuous | -157,846 | -240,053 | -157,128 | -230,026 | -246,290 |
| Net Income | $-157,846 | $-240,053 | $-157,128 | $-230,026 | $-246,290 |
| EPS Basic Total Ops | -1.62 | -2.94 | -2.01 | -3.00 | -3.77 |
| EPS Basic Continuous Ops | -1.62 | -2.94 | -2.01 | -3.00 | -3.77 |
| EPS Diluted Total Ops | -1.62 | -2.94 | -2.01 | -3.00 | -3.77 |
| EPS Diluted Continuous Ops | -1.62 | -2.94 | -2.01 | -3.00 | -3.77 |
| EPS Diluted Before Non-Recurring Items | -1.62 | -2.94 | -1.99 | -3.00 | -3.77 |
| EBITDA(a) | $-127,378 | $-162,719 | $-120,956 | $-259,090 | $-217,075 |